Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Buoyed by impressive third-quarter 2012 results and strategies undertaken to reposition itself in an economy that is witnessing an uneven recovery, we have adopted a bullish stance on Central Garden & Pet Company ( CENT - Analyst Report ) . We upgrade our recommendation to Outperform from Neutral with a target price of $11.00.
Central Garden & Pet Company is a leading producer and marketer of premium and value-oriented products focused on the lawn and garden as well as pet supplies markets in the U.S.
Fabulous Quarter
The company’s diversified portfolio of brands has helped Central Garden & Pet establish a healthy commercial relationship with giant retailers such as Wal-Mart Stores Inc. ( WMT - Analyst Report ) , The Home Depot Inc. ( HD - Analyst Report ) and Lowe’s Companies Inc. ( LOW - Analyst Report ) . This provides a significant upside potential for the company, evident from the company’s third-quarter 2012 results.
Central Garden & Pet Company’s quarterly earnings of 47 cents a share came in line with the Zacks Consensus Estimate, and surged 51.6% from 31 cents earned in the prior-year quarter on the back of increased marketing efforts, brand-building initiatives, and product innovation that helped drive consumer demand.
The company’s top line registered an increase of 10% to $533.8 million, reflecting sales increase across Garden and Pet segments. Moreover, the reported net sales surpassed the Zacks Consensus Estimate of $506 million. Pet segment sales jumped 19% year over year to $271.3 million, whereas Garden segment sales climbed 2% to $262.5 million.
Strategies to Step Up
For 2012, the company’s primary focus is on streamlining its cost structure and increasing operating efficiencies in order to improve its margins and concentrate on revenue growth through promotions. The company’s long-term target is to attain growth of at least 10% in the top line, and achieve operating margins in the range of 10% to 15%. The company also targets a $30 million yearly savings in cost as it exits 2012.
The company intends to transform into an integrated, multi-brand company from a portfolio of stand-alone businesses, by restructuring and reorganizing operating units and consolidating manufacturing facilities and logistics centers.
Central Garden & Pet has lowered the count of sales and logistics warehouses to 27 in fiscal 2011 from 34 in fiscal 2008. The company has closed 1 manufacturing facility and 5 warehouses, and hinted at closing 2 more facilities in the fourth quarter.
The company also intends to manage its inventory level efficiently in order to systematically manage working capital. Another significant area of savings is the SKU rationalization, and the company aims to lower its total SKU count by at least 30% to 35% by the end of 2014. Since, the beginning of the year, the company has lowered its SKU count by 13%.
Closing Comment
The above analysis supports our unbiased view, and advocates our bullish stance on the Central Garden & Pet, which is well defined through our Zacks #2 Rank that translates into a short-term “Buy” rating.
Read the full reports :
Analyst Report on WMT
Analyst Report on HD
Analyst Report on LOW
Analyst Report on CENT